Alder BioPharma (ALDR) Misses Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts ALDR Hot Sheet
Join SI Premium – FREE
Alder BioPharma (NASDAQ: ALDR) reported Q4 EPS of ($0.97), $0.07 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
- Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
